Manfred Keller

828 total citations
26 papers, 655 citations indexed

About

Manfred Keller is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Manfred Keller has authored 26 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 4 papers in Surgery. Recurrent topics in Manfred Keller's work include Inhalation and Respiratory Drug Delivery (15 papers), Cystic Fibrosis Research Advances (8 papers) and Asthma and respiratory diseases (5 papers). Manfred Keller is often cited by papers focused on Inhalation and Respiratory Drug Delivery (15 papers), Cystic Fibrosis Research Advances (8 papers) and Asthma and respiratory diseases (5 papers). Manfred Keller collaborates with scholars based in Germany, United States and Switzerland. Manfred Keller's co-authors include M. Knoch, Winfried Möller, Uwe Schuschnig, Gabriele Meyer, K Häußinger, Oliver Denk, Kitty Leung, Allan L. Coates, Jeffrey Shi Kai Chan and Martin Charron and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Manfred Keller

23 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manfred Keller Germany 16 496 131 96 90 80 26 655
M. Knoch Germany 12 369 0.7× 84 0.6× 38 0.4× 78 0.9× 33 0.4× 25 526
Sandrine Le Guellec France 11 194 0.4× 37 0.3× 88 0.9× 67 0.7× 60 0.8× 22 357
SW Clarke United Kingdom 13 466 0.9× 212 1.6× 13 0.1× 27 0.3× 10 0.1× 14 560
John Massie Australia 7 955 1.9× 108 0.8× 18 0.2× 92 1.0× 4 0.1× 9 1.1k
Robert P. Tomkiewicz Canada 13 506 1.0× 152 1.2× 6 0.1× 49 0.5× 19 0.2× 16 632
Kachorn Seresirikachorn Thailand 12 100 0.2× 170 1.3× 154 1.6× 124 1.4× 6 0.1× 51 515
Dinesh Saralaya United Kingdom 11 269 0.5× 270 2.1× 10 0.1× 65 0.7× 7 0.1× 32 445
Guillermo Suárez-Cuartín Spain 15 598 1.2× 177 1.4× 15 0.2× 26 0.3× 4 0.1× 43 926
Songklot Aeumjaturapat Thailand 12 89 0.2× 113 0.9× 178 1.9× 162 1.8× 4 0.1× 40 506
Takeshi Kawai Japan 14 149 0.3× 58 0.4× 13 0.1× 62 0.7× 6 0.1× 62 574

Countries citing papers authored by Manfred Keller

Since Specialization
Citations

This map shows the geographic impact of Manfred Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Keller more than expected).

Fields of papers citing papers by Manfred Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Keller. The network helps show where Manfred Keller may publish in the future.

Co-authorship network of co-authors of Manfred Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Keller. A scholar is included among the top collaborators of Manfred Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Keller. Manfred Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barnes, Ashley, et al.. (2025). Fatal Donor-Derived KSHV Inflammatory Cytokine Syndrome (KICS) in Lung Transplant. The Journal of Heart and Lung Transplantation. 44(4). S309–S309.
2.
Chrystyn, Henry, et al.. (2019). Real-life inhaler adherence and technique: Time to get smarter!. Respiratory Medicine. 158. 24–32. 35 indexed citations
3.
Donnachie, Ewan, Antonius Schneider, Stefan Wagenpfeil, et al.. (2014). The Effects of Theophylline on Hospital Admissions and Exacerbations in COPD Patients. Deutsches Ärzteblatt international. 111(17). 293–300. 10 indexed citations
4.
Griese, Matthias, Gerhard Börner, Oliver Denk, et al.. (2013). A Pharmacokinetics and Safety Comparison of a Highly Concentrated Tobramycin Solution with TOBI. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 27(3). 185–192. 10 indexed citations
5.
Mehring, Michael, et al.. (2012). Disease Management Programs for Patients With Asthma in Germany: A Longitudinal Population-Based Study. Respiratory Care. 58(7). 1170–1177. 23 indexed citations
6.
Möller, Winfried, et al.. (2011). Nasally inhaled pulsating aerosols: lung, sinus and nose deposition. Rhinology Journal. 49(3). 286–291. 34 indexed citations
7.
Scherer, Thomas, et al.. (2010). A Technical Feasibility Study of Dornase Alfa Delivery with eFlow® Vibrating Membrane Nebulizers: Aerosol Characteristics and Physicochemical Stability. Journal of Pharmaceutical Sciences. 100(1). 98–109. 34 indexed citations
8.
Coates, Allan L., Oliver Denk, Kitty Leung, et al.. (2010). Higher Tobramycin concentration and vibrating mesh technology can shorten antibiotic treatment time in cystic fibrosis. Pediatric Pulmonology. 46(4). 401–408. 35 indexed citations
9.
Keller, Manfred, et al.. (2010). Have inadequate delivery systems hampered the clinical success of inhaled disodium cromoglycate? Time for reconsideration. Expert Opinion on Drug Delivery. 8(1). 1–17. 26 indexed citations
10.
Möller, Winfried, et al.. (2010). Pulsating aerosols for drug delivery to the sinuses in healthy volunteers. Otolaryngology. 142(3). 382–388. 53 indexed citations
11.
12.
Adler, Kerstin, et al.. (2010). German new onset diabetes in the young incident cohort study: DiMelli study design and first-year results.. PubMed. 7(3). 202–8. 24 indexed citations
13.
Behr, Jürgen, G. Zimmermann, Rainer Baumgartner, et al.. (2009). Lung Deposition of a Liposomal Cyclosporine A Inhalation Solution in Patients after Lung Transplantation. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 22(2). 121–130. 58 indexed citations
14.
15.
Haltner‐Ukomadu, Eleonore, et al.. (2008). Comparative permeability and diffusion kinetics of cyclosporine A liposomes and propylene glycol solution from human lung tissue into human blood ex vivo. European Journal of Pharmaceutics and Biopharmaceutics. 70(3). 758–764. 10 indexed citations
16.
Coates, Allan L., Maria Green, Kitty Leung, et al.. (2008). Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: A pilot project. Pediatric Pulmonology. 43(8). 753–759. 35 indexed citations
17.
Keller, Manfred, et al.. (2008). Prävalenzen von Folge- und Begleiterkrankungen des Typ-2-Diabetes. DMW - Deutsche Medizinische Wochenschrift. 133(33). 1667–1672. 3 indexed citations
18.
Keller, Manfred, et al.. (2008). Using Infant Deposition Models To Improve Inhaler System Design. UWA Profiles and Research Repository (University of Western Australia). 1. 221–231. 1 indexed citations
19.
Tiddens, Harm A.W.M., et al.. (2005). In Vitro Determination of the Optimal Particle Size for Nebulized Aerosol Delivery to Infants. Journal of Aerosol Medicine. 18(2). 225–235. 50 indexed citations
20.
Keller, Manfred. (1999). Innovations and perspectives of metered dose inhalers in pulmonary drug delivery. International Journal of Pharmaceutics. 186(1). 81–90. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Knoch Breakdown of academic impact, for papers by Sandrine Le Guellec Breakdown of academic impact, for papers by SW Clarke Breakdown of academic impact, for papers by John Massie Breakdown of academic impact, for papers by Robert P. Tomkiewicz Breakdown of academic impact, for papers by Kachorn Seresirikachorn Breakdown of academic impact, for papers by Dinesh Saralaya Breakdown of academic impact, for papers by Guillermo Suárez-Cuartín Breakdown of academic impact, for papers by Songklot Aeumjaturapat Breakdown of academic impact, for papers by Takeshi Kawai
Rankless by CCL
2026